Omar Danoun: Levetiracetam May Increase Thromboembolic Risk With DOACs
Omar Danoun, Assistant Professor at Michigan State University, Epileptologist at Henry Ford Health System, shared a post on X about a recent article by Kai Michael Schubert et al. published in JAMA Neurology, adding:
“New study suggests Levetiracetam (Keppra) increases clotting risk.
But context matters, this is not a universal effect of the drug itself. The signal is a drug interaction, nearly double thromboembolic risk specifically when combined with DOACs like apixaban or rivaroxaban. Notably, this interaction has not been seen with warfarin.
Levetiracetam alone does not raise clotting risk.
Clinical takeaway, for patients on a DOAC with a history of atrial fibrillation or DVT, consider switching from levetiracetam to an alternative such as lamotrigine that lacks this interaction, or discuss whether warfarin might be a suitable option instead.”
Title: Safety of Antiseizure Medications During Direct Oral Anticoagulant Therapy in Epilepsy
Authors: Kai Michael Schubert, Carolina Ferreira-Atuesta, Arunachalam Soma, Johan Zelano, David J. Seiffge, Francesco Brigo, Eugen Trinka, Nishant K. Mishra, Emilio Russo, Gregory Y. H. Lip, Gashirai K Mbizvo, Marian Galovic
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause